The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1

BACKGROUND: IL-13 is one of many cytokines responsible for the chronic inflammation of asthma. AIM: The aim of this study was to determine the effect of combined therapy ICS/LABA and ICS/LABA plus Montelukast in patients with uncontrolled severe persistent asthma by analyzing of serum IL-13 and FEV1...

Descripción completa

Detalles Bibliográficos
Autores principales: Janeva, Elena Jovanovska, Goseva, Zlatica, Gjorchev, Angjelko, Debreslioska, Angela, Spiroski, Mirko, Zafirova, Beti, Dimitrova, Magdalena Genadieva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institute of Immunobiology and Human Genetics 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877865/
https://www.ncbi.nlm.nih.gov/pubmed/27275233
http://dx.doi.org/10.3889/oamjms.2015.053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877865/
https://www.ncbi.nlm.nih.gov/pubmed/27275233
http://dx.doi.org/10.3889/oamjms.2015.053

Ejemplares similares